Reading Time: 3 minutes

BIO International Convention
, the world’s premier life sciences
event, today wrapped up four days of meetings, presentations and
discussions designed to advance biotechnology innovation and solutions
to the world’s toughest challenges today.

United under the Convention theme, “It Starts With One,” companies,
academic centers, patient groups, researchers, regulatory leaders and
investors worked to progress approaches in key areas, such as drug
development, patient access, gene therapy, diversity and inclusion,
opioids, renewable fuels and agriculture.

Hosted by the Biotechnology Innovation Organization (BIO), this year’s
Convention drew 17,307 attendees from 49 states, the District of
Columbia, Puerto Rico and 65 countries to Philadelphia and its
burgeoning biotech community.

“BIO 2019 perfectly reflected our theme and organization’s belief that
the singular steps we take each day can have a significant global impact
on health and biotechnology,” said Joanne Duncan, President, Membership
and Business Operations at BIO. “We believe many of these first steps
took place this week and that attendees are now better prepared to
continue marching forward to deliver innovations that heal, feed and
fuel the world.”

BIO 2019 included over 1,800 exhibitors, more than 800 speakers, over
250 company presentations, 126 educational sessions, nine super
sessions, seven fireside chats and 18 education tracks. Siddhartha
Mukherjee, Pulitzer Prize-winning author, physician and oncologist, and
Jamie Dimon, Chairman and CEO of JPMorgan Chase, delivered keynote
addresses that put a spotlight on current and future opportunities in
gene therapy and improving diversity and inclusion within the biotech
industry, respectively.

The Convention continued to demonstrate that it is the premiere
networking event for the biotechnology industry. Facilitated by BIO’s
One-on-One Partnering™ system, BIO 2019 hosted more than 48,500
partnering meetings. BIO 2019 also featured a Free Student Day, offering
eligible participants a one-day Exhibition Access registration and the
invaluable opportunity to meet with biotech industry leaders and

During Convention, BIO also announced that Jeremy Levin, Chairman and
Chief Executive Officer of Ovid Therapeutics, has been named the new
Chair of its Board of Directors for the 2019-2020 term.

BIO 2019 was co-chaired by Life Sciences Pennsylvania, BioNJ and
Delaware Bio.

“Life Sciences Pennsylvania was honored to co-host the 2019 BIO
International Convention,” said Christopher P. Molineaux, President and
CEO of Life Sciences Pennsylvania. “The tri-state region is home to top
pharma and biotech companies, universities, academic medical centers and
research institutions and we’re grateful to have been able to showcase
the region’s contributions to business and science during this week.”

“The past four days of programming have enabled the leading visionaries,
problem solvers and innovators across the Tri-State region and biotech
ecosystem to connect, collaborate and address the industry’s top
issues,” said Debbie Hart, President and CEO, BioNJ and co-chair of the
2019 BIO International Convention. “We now set our sights on the future
of biotech innovation, inspired by the progress of the past week.”

“It’s been a pleasure to see the BIO 2019 programming come to life in
ways that provide real value for Convention attendees,” said Helen
Stimson, President and CEO, DelawareBio and co-chair of the 2019 BIO
International Convention. “The past four days have set the stage for
what’s next for our industry in the year ahead and beyond and we’re
honored to have co-hosted this prestigious event.”

BIO 2020 will return to San Diego for the fourth time from June 8-11.

In 2021, the Convention will take place in Boston from June 14-17.

Follow the 2019 Convention @BIOConvention
and join the conversation @IAmBIOtech.

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter


Biotechnology Innovation Organization (BIO)

Twitter: @IAmBiotech